EJC Skin Cancer

Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations

Pub Date : 2025-01-01 DOI: 10.1016/j.ejcskn.2025.100285 Sophia Kreft , Tommaso Bosetti , Rebecca Lee , Paul Lorigan

Improved prognostic guidance with 31-gene expression profiling for patients with stage IIB-IIC cutaneous melanoma: a SEER collaboration

Pub Date : 2025-01-01 DOI: 10.1016/j.ejcskn.2025.100387 B. Moody , B. Martin , A. Hanson , V. Petkov

Italian interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: focus on time to onset of adverse events

Pub Date : 2025-01-01 DOI: 10.1016/j.ejcskn.2025.100335 L. Scarpato , P.A. Ascierto , M. Scalvenzi , A. Villani , P. Bossi , A. Alberti , V. De Giorgi , L. Licitra , M.C. Fargnoli , P. Savoia , M. Guida , F. Spagnolo , F. De Galitiis , I. Stanganelli , K. Peris